NEW YORK (GenomeWeb) – The sequencing service center Novogene and molecular diagnostics and services company AITbiotech will form a new joint venture called NovogeneAIT Genomics Singapore, and will establish a whole-genome sequencing center in Singapore.
The new center will provide whole-genome sequencing and bioinformatics based on Illumina’s HiSeq X instruments, and will support public research projects and large-scale sequencing initiatives in Singapore and the broader region. It will also collaborate with the Genome Institute of Singapore to use whole-genome sequencing for cancer diagnosis and to identify treatments based on patients’ molecular profile.
In addition, NovogeneAIT and GIS will work to develop new applications for next-generation sequencing.
“The center is the first major project for NovogeneAIT and is an important milestone for our company,” Novogene CEO Ruiqian Li said in a statement.
GIS Executive Director Ng Huck Hui added, “Such public-private partnerships will prove to be highly beneficial as it leverages the strengths of both parties to advance genomic science and medicine in Singapore, as well as to create successful local biotech companies.”